Skip to content

Clinical trials

Phase 1 Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 1 Clear all

151 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20042
20056
20065
20075
200811
20099
20108
20117
20125
20134
20144
20159
20167
20174
20181
20196
20207
20219
202212
202311
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Terminated24
Recruiting16
Unknown status12
Active, not recruiting11
Withdrawn4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Akamis Bio5
Pfizer5
Amgen4
Providence Health & Services4
Astellas Pharma Inc3
AstraZeneca3
Blueprint Medicines Corporation3
Celgene3
H. Lee Moffitt Cancer Center and Research Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma151
Neoplasms51
Neoplasm Metastasis24
Carcinoma, Non-Small-Cell Lung23
Squamous Cell Carcinoma of Head and Neck16
Lung Neoplasms15
Adenocarcinoma13
Colorectal Neoplasms13
Melanoma13
Sarcoma13

Trials

Showing 76 to 100 of 151. Each trial links to its page on Pharma Observatory.

51 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.